Stroke

This is a randomized clinical trial to determine the efficacy and safety of andexanet compared to usual care in patients presenting with acute intracerebral hemorrhage within 6 hours...

MultiStem is an allogeneic, regenerative medicine advanced therapy indicated for treatment of acute ischemic stroke within 36 hours after symptom onset. The primary objective of this study is...

DISCOVERY is a prospective, multicenter, observational, nested-cohort study with the overarching objectives to identify specific stroke subtypes associated with risk of PSCID in diverse US populations and elucidate...

What is the FASTEST Trial?  Barrow Neurological Institute is conducting a research study of the emergency treatment of patients with bleeding in the brain, also called intracerebral hemorrhage....

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema following Large Hemispheric Infarction This is...